Connect
← Return to Anyone in Clinical trial for MEK Inhibitor IMM-1-104. NCT05585320?
Discussion
Anyone in Clinical trial for MEK Inhibitor IMM-1-104. NCT05585320?
Pancreatic Cancer | Last Active: Jul 24, 2025 | Replies (33)Comment receiving replies
I see in this article that the FDA has given fast track designation to IMM-1-104 for use as a therapeutic option in patients with pancreatic ductal adenocarcinoma (PDAC) who have progressed on 1 line of treatment.
- FDA Grants Fast Track Status to IMM-1-104 for Pancreatic Cancer https://www.onclive.com/view/fda-grants-fast-track-status-to-imm-1-104-for-pancreatic-cancer
Here is a link to the clinical trial itself
- A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors http://cancer.gov/research/participate/clinical-trials-search/v
@sandyk62, are you eligible for the study? Have you enrolled?
Replies to "I see in this article that the FDA has given fast track designation to IMM-1-104 for..."
My husband is enrolled with NextOncology, we are new to this, same drugs so assume same trial? Just started last week, side effects minimal so far, which is great.
Connect
I will be at Mayo Rochester next week for all my pre-screening appts. Mayo had recommended this trial, it will be a 1st line treatment since I now have a few liver lesions since my whipple last September. So if all goes well next week I will start this clinical trial in a couple of weeks at Mayo.
Thank you for the follow up informational links.